Previous 10 | Next 10 |
MIAMI BEACH, Fla., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological dis...
Palm Beach, FL –– February 3, 2022 – FinancialNewsMedia.com News Commentary – Multiple Sclerosis (MS) is an immune-mediated disease of the central nervous system. It is characterized by demyelination, inflammation, and degenerative changes such ...
MIAMI BEACH, Fla., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders...
MIAMI BEACH, Fla., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological dis...
3 Hot Penny Stocks to Watch With 2022 Only Days Away With a new year only a few days away, investors continue to search for the best penny stocks to buy. Right now, there is a sizable amount of bullish sentiment with penny stocks despite an overwhelming fear of the unknown. With the...
It looks like Santa rally may finally come to the US Stock Market. Let’s take a look at some of the hot stocks on the big boards today. Shares of 22nd Century Group, Inc. (NASDAQ: XXII) gained $0.85 after the company announced that the U.S. Food and Drug Administration (FDA) has author...
3 Penny Stocks For Your Watchlist As the Bull Run Continues With penny stocks and blue chips seeing another bull run today, investors are excited about what the future could hold. Despite fears surrounding the Omicron variant, the Dow managed to jump to near-record highs, up 225 points ...
Gainers: Zhangmen Education (NYSE:ZME) +474%. 22nd Century Group (NASDAQ:XXII) +49%. Pasithea Therapeutics (NASDAQ:KTTA) +36%. Theseus Pharmaceuticals (NASDAQ:THRX) +32%. Qualigen Therapeutics (NASDAQ:QLGN) +32%. Allakos (NASDAQ:ALLK) +27%. REE Automotive (NASDAQ:REE) +26%. View (NASDAQ:VIEW)...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Casino stocks are on the move today thanks to a recent report out of China’s Macau. Source: Maridav/Shutterstock, Inc. This new report has the Chinese government weighing in on casino operations in the count...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pasithea Therapeutics (NASDAQ: KTTA ) stock is heading higher on Thursday even without any recent news from the biotech company. Source: Bukhta Yurii / Shutterstock.com Strangely enough, there’s no real...
News, Short Squeeze, Breakout and More Instantly...
Pasithea Therapeutics Corp. Company Name:
KTTA Stock Symbol:
NASDAQ Market:
Pasithea Therapeutics Corp. Website:
MIAMI, June 13, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis typ...
-- PAS-004 inhibition of in vitro NRAS cell lines does not plateau in contrast to approved MEK inhibitors -- -- PAS-004 inhibition of in vitro NRAS cell lines is greater than selumetinib and binimetinib and similar to trametinib -- -- PAS-004 shows superior activity versus selumetinib and...